Cita APA

Vallejo Vaz, A. J., Leiter, L. A., Prato, S. d., Taskinen, M., Müller-Wieland, D., Bujas-Bobanovic, M., . . . Ray, K. K. (2020). Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab.

Citación estilo Chicago

Vallejo Vaz, Antonio Javier, et al. Triglyceride Concentrations and Non-high-density Lipoprotein Cholesterol Goal Attainment in the ODYSSEY Phase 3 Trials With Alirocumab. 2020.

Cita MLA

Vallejo Vaz, Antonio Javier, et al. Triglyceride Concentrations and Non-high-density Lipoprotein Cholesterol Goal Attainment in the ODYSSEY Phase 3 Trials With Alirocumab. 2020.